WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMLX past revenue growth

How has AMLX's revenue growth performed historically?
Company
1,612.94%
Industry
144.63%
Market
17.55%
AMLX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMLX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMLX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMLX earnings and revenue history

Current Revenue
$380.8M
Current Earnings
$49.3M
Current Profit Margin
12.9%

AMLX Return on Equity

Current Company
12.4%
Current Industry
-63.5%
Current Market
188%
AMLX's Return on Equity (12.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMLX announces earnings.

AMLX Return on Assets

Current Company
10.7%
Current Industry
2.9%
AMLX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMLX Return on Capital Employed

Current Company
12.47%
Current Industry
19.5%
AMLX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMLX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMLX$380.79M$55.39M$49.27M+304.24%N/A
PDSB$0.00-$42.87M-$42.94MN/AN/A
KPTI$146.03M-$118.42M-$143.10M+36.93%N/A
BCAB$0.00-$122.24M-$123.46M-100.00%N/A
RLMD$0.00-$98.79M-$98.79MN/AN/A
View Top Biotech Stocks

AMLX earnings dates

Next earnings date
Jun 6, 2024

Amylyx Pharmaceuticals Earnings & Revenue FAQ

What were AMLX's earnings last quarter?

On Invalid Date, Amylyx Pharmaceuticals (NASDAQ: AMLX) reported Q4 2023 earnings per share (EPS) of $0.07, up 111.29% year over year. Total Amylyx Pharmaceuticals earnings for the quarter were $4.73 million. In the same quarter last year, Amylyx Pharmaceuticals's earnings per share (EPS) was -$0.62.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.

What was AMLX's earnings growth in the past year?

As of Q2 2024, Amylyx Pharmaceuticals's earnings has grown year over year. Amylyx Pharmaceuticals's earnings in the past year totalled $49.27 million.

What is AMLX's earnings date?

Amylyx Pharmaceuticals's earnings date is Invalid Date. Add AMLX to your watchlist to be reminded of AMLX's next earnings announcement.

What was AMLX's revenue last quarter?

On Invalid Date, Amylyx Pharmaceuticals (NASDAQ: AMLX) reported Q4 2023 revenue of $108.45 million up 395.54% year over year. In the same quarter last year, Amylyx Pharmaceuticals's revenue was $21.89 million.

What was AMLX's revenue growth in the past year?

As of Q2 2024, Amylyx Pharmaceuticals's revenue has grown 1,612.94% year over year. This is 1,468.31 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Amylyx Pharmaceuticals's revenue in the past year totalled $380.79 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.